Home / Investor Library / HealthShares in the News / HealthShares™ Announces Changes to the HealthShares™ Neuroscience and Composite Indices

HealthShares in the News

04.18.2007

HealthShares™ Announces Changes to the HealthShares™ Neuroscience and Composite Indices
New York (April 18, 2007) – HealthShares™ Inc., an investment company with a series of 20 underlying fund portfolios, today announced it has been informed by Standard & Poor’s, the calculating agent for the HealthShares™ Indices, that effective at the opening of trading on Monday April 23, 2007, Neurochem Inc. (Nasdaq: NRMX) will replace New River Pharmaceuticals (Nasdaq: NRPH) in the HealthShares™ Neuroscience Index. Additionally, Aspreva Pharmaceuticals Corp. (Nasdaq: ASPV) will replace New River Pharmaceuticals in the HealthShares™ Composite Index. Companies included in the Neuroscience Index are engaged in the research, clinical development and commercialization of therapeutic agents for the treatment of a wide variety of neurological and psychiatric disorders including Alzheimer’s, Parkinson’s, Huntington’s, schizophrenia, anxiety, depression, epilepsy, pain and sleep disorders.

HealthShares™ Announces Changes to the HealthShares™ Neuroscience and Composite Indices


<< back to news